Home Tags ContraFect Corp.
Tag: ContraFect Corp.
The Yonkers biotechnology company priced 5 million shares of common stock at $2.00 per share.
Ricciardi will continue to serve in her role as a director of ContraFect.
Steven C. Gilman Gilman will remain as chairman and is expected to return in the third quarter of 2017, according to the company announcement.
ContraFect Corp. in Yonkers will collaborate with a Chinese health agency to develop the Yonkers biotech company's new treatment for influenza.